Pharma CEOs

Why CEO Replacement Is Good News For Dendreon

Why CEO Replacement Is Good News For Dendreon

Forbes

Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says

Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says

Bloomberg

AZ chief: Emerging markets are tougher than you think

AZ chief: Emerging markets are tougher than you think

Fierce Pharma

Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year

Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year

Bloomberg

Bristol CEO sees fruits of company transformation

Bristol CEO sees fruits of company transformation

Yahoo/AP

Pfizer CEO focused on reorganizing research, creating more partnerships, allocating capital

Pfizer CEO focused on reorganizing research, creating more partnerships, allocating capital

Yahoo/AP

Amarin CEO Seeks Redemption And Investors at JP Morgan Conference

Amarin CEO Seeks Redemption And Investors at JP Morgan Conference

TheStreet.com

Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks

Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks

Yahoo/AP

Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says

Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says

Bloomberg

Merck CEO: This year will be better than 2011

Merck CEO: This year will be better than 2011

Yahoo/AP